Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.58B P/E 8.01 EPS this Y - Ern Qtrly Grth -10.70%
Income 8.88B Forward P/E - EPS next Y - 50D Avg Chg -3.00%
Sales 598.32B PEG - EPS past 5Y - 200D Avg Chg 9.00%
Dividend 5.00% Price/Book 0.14 EPS next 5Y - 52W High Chg -16.00%
Recommedations - Quick Ratio 1.08 Shares Outstanding 624.13M 52W Low Chg 66.00%
Insider Own - ROA 3.33% Shares Float 1.34B Beta 0.83
Inst Own 0.01% ROE 12.37% Shares Shorted/Prior -/- Price 15.22
Gross Margin 8.05% Profit Margin 1.49% Avg. Volume 20,250 Target Price -
Oper. Margin 2.30% Earnings Date Apr 26 Volume 9,660 Change -4.01%
About SINOPHARM GROUP CO. LTD. UNSP A

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.